Theraderm
FDA Label NDC 16903-169

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Manna Omni International Incorporated for the product Theraderm (NDC 16903-169). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: for external use only., keep out of the reach of children., indications & usage, dosage:, other ingredients:, active ingredients:, purpose:, use:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.